The total return over the past 12 months is -16.41% vs. +19.98% for the S&P 500. So far it's up -20.86% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (16.41%) | +1.54% | (4.90%) | +16.71% | +19.33% | +17.01% |
| Total Return CAGR | (16.41%) | +1.54% | (4.90%) | +16.71% | +19.33% | +17.01% |
| Revenue CAGR | +12.77% | +9.02% | +8.37% | +10.42% | +9.52% | +9.94% |
| Net Income CAGR | +15.62% | +12.92% | +9.38% | +18.90% | +14.16% | +13.88% |
| EPS CAGR | +17.69% | +17.49% | +14.07% | +20.32% | +17.12% | +16.70% |
| Free Cash Flow CAGR | +61.51% | +27.54% | +12.49% | +19.48% | +15.49% | +15.00% |
| Operating Cash Flow CAGR | +51.00% | +22.35% | +12.17% | +16.98% | +13.98% | +12.79% |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
IDEXX Laboratories, Inc. (IDXX)
| Year | Start price | End price | IDXX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $676.53 | $535.38 | (20.86%) | +13.55% | (34.41%) |
| 2025 | $413.44 | $676.53 | +63.63% | +17.72% | +45.91% |
| 2024 | $555.05 | $413.44 | (25.51%) | +24.89% | (50.40%) |
| 2023 | $407.96 | $555.05 | +36.06% | +26.19% | +9.87% |
| 2022 | $658.46 | $407.96 | (38.04%) | (18.17%) | (19.87%) |
| 2021 | $499.87 | $658.46 | +31.73% | +28.74% | +2.99% |
| 2020 | $261.13 | $499.87 | +91.43% | +18.37% | +73.06% |
| 2019 | $186.02 | $261.13 | +40.38% | +31.22% | +9.16% |
| 2018 | $156.38 | $186.02 | +18.95% | (4.56%) | +23.51% |
| 2017 | $117.27 | $156.38 | +33.35% | +21.70% | +11.65% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
